Sugar Maple Asset Management, LLC

Sugar Maple Asset Management, LLC reported 81 holdings worth US$155M as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Jul 28, 2026

Sugar Maple Asset Management, LLC reported 81 holdings worth US$155M as of Jun 30, 2026. Largest: Abbvie Inc., Abbott Laboratories and Palo Alto Networks, Inc. Filed Jul 28, 2026 (Form 13F).

Holdings
81
Value as reported
US$155M

The filing in full

CompanySharesValue as reported% of portfolio
Abbvie Inc.56,269US$14.2M9.1%
Abbott Laboratories67,187US$6.1M3.9%
Palo Alto Networks, Inc.8,558US$2.92M1.9%
Nicolet Bankshares Inc.14,457US$2.39M1.5%
Alliant Energy Corporation20,183US$1.54M0.99%
Nvidia Corporation5,975US$1.2M0.77%
Alphabet Inc (google) Class C2,703US$966K0.62%
Amazon.com, Inc.3,249US$774K0.50%
Tempus Ai, Inc.12,250US$710K0.46%
Apple Inc2,093US$606K0.39%
Iovance Biotherapeutics, Inc.135KUS$562K0.36%
Microsoft Corp.1,301US$485K0.31%
Space Exploration Technologies Corp2,800US$478K0.31%
Rubrik, Inc.5,500US$442K0.28%
Transmedics Group, Inc.6,000US$399K0.26%
Snap Inc.87,700US$389K0.25%
Kimberly-clark Corporation3,470US$381K0.25%
Talkspace, Inc.70,000US$364K0.23%
Asml Holding Nv175US$348K0.22%
Aquestive Therapeutics, Inc.83,060US$346K0.22%
Astera Labs, Inc.500US$242K0.16%
Procter & Gamble Company (the)1,566US$230K0.15%
Adma Biologics Inc15,500US$130K0.08%
Under Armour, Inc.10,221US$65,3100.04%
Applovin Corporation0US$00.00%
Cheniere Energy, Inc.0US$00.00%
Halozyme Therapeutics, Inc.0US$00.00%
Medline Inc.0US$00.00%

Source

View original at SEC

Related